Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IMGENEX India Pvt. Ltd. is an independent Indian biotech company founded in 2004, specializing in affordable biologics, research reagents, and diagnostics. The company develops biosimilars, recombinant proteins, and diagnostic kits, with several therapeutic programs in pre-clinical to early development stages. It is recognized for its indigenous diagnostic solutions, including COVID-19 rapid antigen tests, and is expanding its GMP manufacturing capabilities for therapeutic antibodies and proteins.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IMGENEX India.